Beliefs associated with fecal occult blood test and colonoscopy use at a worksite colon cancer screening program

Journal of Occupational and Environmental Medicine

Volumn 45, Issue 8, 2003, Pages 891-898

  Menon, Usha ^a   Champion, Victoria L ^b   Larkin, Gregory N ^c   Zollinger, Terrell W ^d   Gerde, Priscilla M ^c   Vernon, Sally W ^e  

^a UNIVERSITY OF UTAH   (United States)

^b INDIANA UNIVERSITY SCHOOL OF NURSING   (United States)

^c ELI LILLY AND COMPANY   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER MORTALITY; CANCER SCREENING; CAUCASIAN; COLON CANCER; COLONOSCOPY; COLORECTAL CARCINOMA; HEALTH SURVEY; HUMAN; MORBIDITY; OCCULT BLOOD TEST; RISK FACTOR;

ADULT; COLONOSCOPY; COLORECTAL NEOPLASMS; DRUG INDUSTRY; FECES; FEMALE; HEALTH PROMOTION; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; MIDWESTERN UNITED STATES; OCCULT BLOOD; OCCUPATIONAL HEALTH SERVICES; PATIENT ACCEPTANCE OF HEALTH CARE; QUESTIONNAIRES; SEX FACTORS;

EID: 0041660640     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jom.0000083038.56116.30     Document Type: Article

References (56)

1. American Cancer Society: Cancer Facts and Figures 2003. Atlanta, GA: American Cancer Society; 2003.
2. Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: clinical guidelines and rationale. Gasteroenterology. 1997;1122:594-642.
3. TM PDQ. Available online: http://www. nih.nci.gov. Retrieved December 1999.
4. Winawer SJ, Zauber AG, O'Brien MJ, et al. The National Polyp Study. Design, methods, and characteristics of patients with newly diagnosed polyps. The National Polyp Study Workgroup. Cancer. 1992;70(5 Suppl):1236-1245.
5. Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med. 1993;32927:1977-1981.
6. American Cancer Society. Cancer Facts and Figures. Atlanta, GA: American Cancer Society; 1999.
7. American Cancer Society. Cancer Facts and Figures. Atlanta, GA: American Cancer Society; 2002.
8. National Cancer Institute. Conquering Colorectal Cancer: A Blueprint for the Future - The Report of the Colorectal Cancer Progress Review Group). Bethesda, MD: Department of Health and Human Services; 2000.
9. Ries LAG, Wingo PA, Miller DS, et al. The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer. Cancer. 2000;88:2398-2424.
10. Centers for Disease Prevention & Control. Data 2010. Available online: http:// www.health.gov/healthypeople. Retrieved November 2000.
11. United States Department of Health and Human Services. Healthy People, 2010. Available online: http://www.healthgov. Retrieved January, 2000.
12. Lipkus IM, Rimer BK, Lyna PR, Pradhan AA, Conoway M, Woods-Powell CT. Colorectal cancer screening patterns and perceptions of risk among African American users of community health center. J Community Health. 1996;26:409-427.
13. Montano DE, Phillips WR. Cancer screening by primary care physicians: a comparison of rates obtained from physician self-report, patient survey, and chart audit. Am J Public Health. 1996;85:795-800.
14. Cokkinides VE, Chao A, Smith RA, Vernon SW, Thun MJ. Correlates of under-utilization of colorectal cancer screening among U. S adults, aged 50 years and older. Prev Med. 2003;36:85-91.
15. Selby JV, Friedman, GD, Quesenberry P Jr, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med. 1992;326:653-657.
16. Mewcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst. 1992;8420:1572-1575.
17. Mandell JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood: Minnesota Colon Cancer Control Study. N Engl J Med. 1993;328:1365-1371.
18. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348:1472-1477.
19. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996;348:1467-1471.
20. Citarda F, Tomaselli G, Capocaccia R, Barcherini S, Crespi M. Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. Gut. 2001;48:812-815.
21. Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chefjec G for the Veterans Affairs Cooperative Study Group 380. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. N Engl J Med. 2000;343:162-168.
22. Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DF. Risk of advanced proximal neoplasms in asymtpomatic adults according to the distal colorectal findings. N Engl J Med. 2000;3433:169-174.
23. Vernon SW. Participation in colorectal cancer screening: a review. J Natl Cancer Inst. 1997;89:1406-1422.
24. Green LW, Kreuter MW, eds. Health Promotion Planning: An Educational and Environmental Approach, ed 2. Mountain View, CA: Mayfield Publishing Company; 1991.
25. Strecher VJ, Rosenstock IM. The health belief model. In: Glanz K, Lewis FM, Rimer BK, eds. Health Behavior and Health Education: Theory, Research, and Practice. San Francisco: Jossey-Bass; 1997:41-59.
26. Champion V, Maraj M, Hui S, et al. Comparison of Tailored interventions to increase mammography screening in nonadherent older women. Prev Med. 2003;36:150-158.
27. Skinner CS, Champion VL, Menon U, Seshadri R. Race and education differences in mammography-related perceptions among 1,336 non-adherent women. J Psychosocial Oncol. 2001;20(3):1-17.
28. Champion VL. Development of a benefits and barriers scale for mammography utilization. Cancer Nurs. 1995;181:53-59.
29. Champion VL. Revised susceptibility, benefits and barriers scale for mammography screening. Res Nurs Health. 1999;22:341-348.
30. Arveux P, Durand G, Milan C, et al. Views of the general population on mass screening for colorectal cancer: The Burgundy study. Prev Med. 1992;21:574-581.
31. Bat L, Pines A, Ron E, Niv Y, Arditi E, Shemesh E. A community-based program of colorectal screening in an asymptomatic population: evaluation of screening tests and compliance. Am J Gastroenterol. 1986;188:647-651.
32. Blalock S, McEvoy DB, Sandler R. Participation in fecal occult blood screening: a critical review. Prev Med. 1987;16:9-18.
33. Faivre J, Arveus P, Milan C, Durand G, Lamour J, Bedenne L. Participation in mass screening for colorectal cancer: results of screening and rescreening from the Burgundy study. Eur J Cancer Prev. 1991;1:49-55.
34. Herbert C, Launoy G, Gignoux M. Factors affecting compliance with colorectal cancer screening in France: differences between intention to participate and actual participation. Eur J Cancer Prev. 1997;6:44-52.
35. Herbert C, Launoy G, Thezze Y, et al. Participants' characteristics in a French colorectal cancer mass screening campaign. Prev Med. 1995;245:498-502.
36. Launoy G, Jenet JL, Reaud JM, Ollivier V, Valla A, Gignoux M. Involvement of general practitioners in mass screening. Experience of a colorectal cancer mass screening programme in the Calvados region (France). Eur J Cancer Prev. 1993;2:229-232.
37. Polednak AP. Knowledge of colorectal cancer and use of screening tests in persons 40-74 years of age. Prev Med. 1990;19:213-226.
38. Weinrich SP, Weinrich MC, Boyd MD, Johnson E, Frank-Stromborg M. Knowledge of colorectal cancer among older persons. Cancer Nurs. 1992;155:322-330.
39. Weller DP, Owen N, Hiller JE, Wilson K. Colorectal cancer and its prevention: prevalence of beliefs, attitudes, intentions and behaviour. Aust J Public Health. 1995;191:19-23.
40. Myers RE, Vernon SW, Tilley BC, Lu M, Watts BG. Intention to screening for colorectal cancer screening among white male employees. Prev Med. 1998;27:279-87.
41. Myers RE, Vernon SW, Carpenter AV, et al. Employee response to a company-sponsored program of colorectal and prostate cancer screening. Cancer Detect Prev. 1997;214:380-9.
42. Laville EA, Vernon SW, Jackson GL, Hughes JI. Comparison of participants and nonparticipants in a work site cancer awareness and screening program. J Occup Med. 1989;31:221-232.
43. Krensky B, Niewiarowski T, League R, Herman H, Matz L, Fisher RS. Flexible sigmoidoscopy screening in an industrial setting. Am J Gastroenterol. 1992;87:1759-1762.
44. Neale AV, Demers RY, Herman S. Compliance with colorectal cancer screening in a high-risk occupational group. J Occup Med. 1989;31:1007-1012.
45. Vernon SW, Acquavella JF, Douglass TS, Hughes JI. Factors associated with participation in an occupational program for colorectal cancer screening. J Occup Med. 1989;31:458-463.
46. Rex DK, Lehman GA, Ulbright TM, et al. Colonic neoplasia in asymptomatic persons with negative fecal occult blood tests: Influence of age, gender, and family history. Am J Gastroenterol. 1993;886:825-831.
47. Rawl SR, Champion VL, Menon U, Skinner CS. Validation of scales to measure beliefs and barriers to colorectal cancer screening: Scale development. J Psychosoc Oncol. 2001;19:47-63.
48. Rawl SR, Menon U, Champion VL, Skinner CS. Colorectal cancer screening beliefs. Focus groups with first-degree relatives. Cancer Pract. 2000;81:32-37.
49. rd ed. New York: McGraw Hill; 1996.
50. Polodosky DK. Going the distance - The case for true colorectal cancer screening. N Engl J Med. 2000;3433:207-208.
51. Padgett DK, Yedidia MJ, Kerner J, Mandelblatt J. The emotional consequences of false positive mammography: African-American women's reactions in their own words. Women Health. 2001;33:1-14.
52. Hynes DM, Bastian LA, Rimer BK, Sloane R, Feussner JR. Predictors of mammography use among women veterans. J Womens Health. 1998;72:239-247.
53. Crane LA, Kaplan CP, Bastani R, Scrimshaw SC. Determinants of adherence among health department patients referred for a mammogram. Women Health. 1996;242:43-46.
54. Hall JA, Roter DL, Katz NR. Meta-analysis of correlates of provider behavior in medical encounters. Med Care. 1988;267:657-675.
55. Farrands PA, Griffiths RL, Wright JP. The Frome experiment - Value of screening for colorectal cancer. Lancet. 1981;1:1231-1232.
56. Price JH. Perceptions of colorectal cancer in a socioeconomically disadvantaged population. J Community Health. 1993;18:347-362.